Analyst consensus rating
Viking Therapeutics Analyst Rating: Strong Buy
Direct answer
Viking Therapeutics's consensus rating is Strong Buy.
19 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $95.32.
Forecast evidence checked November 1, 2026.
Get free Viking Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $27.28
- Average price target
- $95.32
- High price target
- $125.00
- Low price target
- $34.00
- Low target gap
- +24.6%
- Target upside
- +249.4%
- High target gap
- +358.2%
- Target range width
- 333.6%
- Consensus rating
- Strong Buy
- Analysts
- 19
- Evidence date
- November 1, 2026
- Valid through
- November 8, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Viking Therapeutics?
Viking Therapeutics has a verified Strong Buy consensus. The same dataset has an average price target of $95.32.
How far are Viking Therapeutics's low and high targets from the recorded price?
The low target implies +24.6%, while the high target implies +358.2%.
How many analysts are included in Viking Therapeutics's consensus?
The verified consensus includes 19 analysts.
How is Viking Therapeutics's target upside or downside calculated?
The average target of $95.32 is divided by the recorded price of $27.28, then one is subtracted to produce +249.4%. This does not guarantee a future return.
When was Viking Therapeutics's analyst forecast verified?
The data was verified on 2026-11-01. The dataset is valid through 2026-11-08.